Almost every day, there is a new story about a drug that had a dangerous or unexpected side effect and that is causing serious illness or injury to patients. Many may wonder how this keeps happening when the Food and Drug Administration is supposed to protect the public from dangerous drugs and when the pharmaceutical manufacturers have an obligation to make sure that their products are tested and safe before those drugs are sold.
A recent article in the Journal of Law, Medicine and Ethics sheds some potential light on how and why pharmaceutical companies keep releasing products that cause so much damage. The proposed answer is institutional corruption, which runs deep at multiple levels. Institutional corruption isn’t any particular rule violation or broken law, but instead as Mercola.com states it refers to “a certain kind of influence, within an economy if influence has a certain effect.” An experienced dangerous drug lawyer in Miami knows that there is plenty of reason to believe that institutional corruption exists on several levels within big pharma, and the recent journal article helps to illustrate the extent of the problem.